Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Sanofi: Wearables are a core part of our digital trials strategy

Pharma firm partners with Parexel on patient sensor work

Sanofi

Sanofi is looking to wearable devices to improve the way it collects data and increase the effectiveness and efficacy of its clinical trial management.

The pharma firm has partnered with service company Parexel, work that begins with a proof of concept study of patient sensors.

Lionel Bascles, global head of clinical sciences and operations at Sanofi, said: “Our objective is to demonstrate the relevance of data collected remotely and the overall feasibility of utilising wearables in clinical trials.

“Wearables are a core component of Sanofi’s digital trials strategy, and represent an important approach to automate patient processes using the latest technologies to bring new therapies to patients sooner.”

Sanofi and Parexel are collaborating on a pilot study of the latter’s patient sensor solution that they hope will demonstrate the scientific and medical viability of using wearables in a clinical trial setting.

In particular they will examine how data from several wearables can be combined into “a single, scalable data system”.

Parexel Informatics president Xavier Flinois said: “We believe the use of wearables to collect data from trial participants represents a breakthrough in the digital transformation within the industry.”

19th July 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics